EFX
54
2
ADT
50
2
CAT
58
-8
AEP
61
-3
EQIX
64
5
CCI
36
2
EMC
47
11
CNP
49
-6
BMY
76
2
APA
53
5
CAG
41
-5
CL
58
2
CF
48
4
AMAT
52
3
CMCSA
44
-2
BAX
38
-12
CSCO
64
6
APH
56
7
CMS
60
-2
BIIB
50
4
EFX
54
2
ADT
50
2
CAT
58
-8
AEP
61
-3
EQIX
64
5
CCI
36
2
EMC
47
11
CNP
49
-6
BMY
76
2
APA
53
5
CAG
41
-5
CL
58
2
CF
48
4
AMAT
52
3
CMCSA
44
-2
BAX
38
-12
CSCO
64
6
APH
56
7
CMS
60
-2
BIIB
50
4
Financhill
Back

ProShares UltraShort MSCI Emerging Markets Vs. Cidara Therapeutics, Inc. Industry Stock Comparison

Sell
35

EEV
ProShares UltraShort MSCI Emerging Markets

Last Price:
$19.64
Seasonality Move:
-4.52%
Buy
80

CDTX
Cidara Therapeutics, Inc.

Last Price:
$220.73
Seasonality Move:
11.35%
Sell
35
ProShares UltraShort MSCI Emerging Markets (EEV) is a Sell

Is ProShares UltraShort MSCI Emerging Markets a Buy, Sell or Hold?

  • The current ProShares UltraShort MSCI Emerging Markets [EEV] share price is $19.72. The Score for EEV is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • EEV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
80
Cidara Therapeutics, Inc. (CDTX) is a Buy

Is Cidara Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Cidara Therapeutics, Inc. [CDTX] share price is $220.80. The Score for CDTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

EEV Stock Price Chart

What is ProShares UltraShort MSCI Emerging Markets's stock price today?

  • The ProShares UltraShort MSCI Emerging Markets share price today is $19.72
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EEV is experiencing buying pressure, which is a positive indicator for future bullish movement.

CDTX Stock Price Chart

What is Cidara Therapeutics, Inc.'s stock price today?

  • The Cidara Therapeutics, Inc. share price today is $220.80
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

EEV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.07 Buy
Relative Strength Index (14 RSI): 48.08 Sell
Chaikin Money Flow: 2846 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.54 - 20.28) Sell
Bollinger Bands (100): (19.21 - 22.79) Sell

CDTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 15.77 Buy
Relative Strength Index (14 RSI): 85.1 Buy
Chaikin Money Flow: 991653 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (219.01 - 220.61) Buy
Bollinger Bands (100): (55.63 - 178.69) Buy

EEV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.91 Sell
20-day SMA: 19.9 Sell
50-day SMA: 19.67 Buy
200-day SMA: 24.88 Sell
8-day EMA: 19.96 Sell
20-day EMA: 19.86 Sell
50-day EMA: 20.07 Sell
200-day EMA: 24.14 Sell

CDTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 220.26 Buy
20-day SMA: 220.14 Buy
50-day SMA: 161.87 Buy
200-day SMA: 73.76 Buy
8-day EMA: 220.14 Buy
20-day EMA: 210.53 Buy
50-day EMA: 173.33 Buy
200-day EMA: 94.53 Buy

ProShares UltraShort MSCI Emerging Markets Earnings Growth & EEV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Cidara Therapeutics, Inc. Earnings Growth & CDTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.86 per share, and an increase next year of $1.78 per share.

ProShares UltraShort MSCI Emerging Markets Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cidara Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):